-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Multiple sclerosis (MS) is a central nervous system itself immune demyelinating disease characterized by a wide heterogeneity
immunity
There are two entities in the earliest stages of the demyelinating spectrum of the central nervous system: Clinical Isolated Syndrome (CIS) and Radiological Isolated Syndrome (RIS)
diagnosis
At the same time, the activation of microglia is related to the disease progression of PMS
Microvesicles (MVs) are extracellular vesicles released by different types of cells (including bone marrow cells) in biological fluids
They included: 601 discharged patients diagnosed with neuroinflammation, neurodegenerative disease, or no neurological disease
Compared with neurodegenerative diseases and the control group, CSF bone marrow microvesicles in patients with neuroinflammation are elevated
CSF bone marrow microvesicles are elevated in patients with neuroinflammation
Microvesicles can distinguish the relapse-remitting group from the control group (ROC curve, AUC=0.
In addition, microbubbles are an independent predictor of the prognosis of the relapse-remitting group and the progression group
This study confirmed that CSF bone marrow microvesicles are a clinically significant biomarker of neuroinflammation and microglia/macrophage activity in the body
CSF bone marrow microvesicles are a clinically significant biomarker of neuroinflammation and microglia/macrophage activity in the body .
Leave a message here